FDA Inspection 1017697 — PolyPeptide SA
The FDA completed an inspection of PolyPeptide SA on Mar 16, 2017 in Braine-L'Alleud. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 16, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Braine-L'Alleud (Belgium)